TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Predictive Oncology ( (POAI) ) is now available.
On November 17, 2025, Predictive Oncology Inc. held a conference call to discuss its third-quarter financial results and its new digital asset strategy. The company is aligning with the Aethir network to capitalize on the growing AI infrastructure market, projected to reach $2.8 trillion by 2029. This strategic move aims to enhance the company’s access to advanced computing power and create new revenue streams through digital assets, potentially impacting its market positioning and stakeholder value.
The most recent analyst rating on (POAI) stock is a Sell with a $7.00 price target. To see the full list of analyst forecasts on Predictive Oncology stock, see the POAI Stock Forecast page.
Spark’s Take on POAI Stock
According to Spark, TipRanks’ AI Analyst, POAI is a Underperform.
The overall stock score is heavily impacted by significant financial challenges, including declining revenues and negative profit margins. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to ongoing losses. The absence of earnings call insights and corporate events does not alter the negative outlook.
To see Spark’s full report on POAI stock, click here.
More about Predictive Oncology
Predictive Oncology Inc. operates in the biotechnology industry, focusing on leveraging artificial intelligence to develop personalized cancer therapies. The company is expanding its market focus by integrating digital asset strategies, particularly through partnerships with entities like DNA Holdings Venture and the Aethir ecosystem, which operates a large decentralized GPU network.
Average Trading Volume: 93,696
Technical Sentiment Signal: Sell
Current Market Cap: $27.29M
For detailed information about POAI stock, go to TipRanks’ Stock Analysis page.